ASX Announcements Due to legal restrictions, only residents of Australia and New Zealand may access ASX announcements that contain information or materials relating to any capital raising. Keyword Search Year None2022202120202019 Date Title 20 May 2022 Becoming a substantial holder 19 May 2022 Litigation Update 03 May 2022 Ceasing to be a substantial holder 02 May 2022 Ceasing to be a substantial holder 29 April 2022 Quarterly Activities/Appendix 4C Cash Flow Report 19 April 2022 Becoming a substantial holder 14 April 2022 Appendix 3G and Appendix 3H 06 April 2022 Company Secretary Appointment 29 March 2022 Becoming a substantial holder 28 March 2022 Initial Director's Interest Notice 24 March 2022 Director Appointment 04 March 2022 S&P DJI Announces March 2022 Quarterly Rebalance 25 February 2022 Final Director's Interest Notice 25 February 2022 MSB Q2 Financial Results and Operational Highlights 25 February 2022 Second Quarter Results Presentation 25 February 2022 Half Yearly Report and Accounts 24 February 2022 Mesoblast Q2 Financial Results Webcast 21 February 2022 Ulcerative Colitis & Crohns Results Presented at ECCO 02 February 2022 Mesoblast Appoints Dr Eric Rose as Chief Medical Officer 31 January 2022 Appendix 4C Quarterly Activity Report 25 January 2022 MSB Presents at Edison Group Global Healthcare Conference 18 January 2022 Cleansing Notice and Appendix 2A 18 January 2022 Proposed issue of securities - MSB 17 January 2022 Appendix 3G, Appendix 3H and Appendix 3Y 12 January 2022 36-Month Results of Phase 3 Trial in Chronic Low Back Pain 12 January 2022 Biotech Showcase 2022 Presentation 06 January 2022 Prospectus for Warrants Related to Oaktree Debt Refinance
